Annual Total Debt
$51.73 M
+$48.65 M+1582.21%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual total debt is currently $51.73 million, with the most recent change of +$48.65 million (+1582.21%) on 31 December 2023. During the last 3 years, it has risen by +$48.65 million (+1582.76%). CRNX annual total debt is now at all-time high.CRNX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$52.54 M
-$779.00 K-1.46%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly total debt is currently $52.54 million, with the most recent change of -$779.00 thousand (-1.46%) on 30 September 2024. Over the past year, it has increased by +$811.00 thousand (+1.57%). CRNX quarterly total debt is now -1.46% below its all-time high of $53.32 million, reached on 30 June 2024.CRNX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +1.6% |
3 y3 years | +1582.8% | +1609.1% |
5 y5 years | +966.8% | +983.5% |
CRNX Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +1582.8% | -1.5% | +1948.3% |
5 y | 5 years | at high | +1582.8% | -1.5% | +1948.3% |
alltime | all time | at high | -1.5% |
Crinetics Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $52.54 M(-1.5%) |
June 2024 | - | $53.32 M(+1.6%) |
Mar 2024 | - | $52.50 M(+1.5%) |
Dec 2023 | $51.73 M(+1582.2%) | $51.73 M(-0.8%) |
Sept 2023 | - | $52.17 M(+1934.0%) |
June 2023 | - | $2.56 M(-9.1%) |
Mar 2023 | - | $2.82 M(-8.2%) |
Dec 2022 | $3.08 M(+0.0%) | $3.08 M(-7.4%) |
Sept 2022 | - | $3.32 M(+29.5%) |
June 2022 | - | $2.56 M(-9.1%) |
Mar 2022 | - | $2.82 M(-8.2%) |
Dec 2021 | $3.07 M(-23.4%) | $3.07 M(-7.5%) |
Sept 2021 | - | $3.32 M(-6.6%) |
June 2021 | - | $3.56 M(-6.1%) |
Mar 2021 | - | $3.79 M(-5.6%) |
Dec 2020 | $4.01 M | $4.01 M(-5.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $4.23 M(-4.7%) |
June 2020 | - | $4.44 M(-4.4%) |
Mar 2020 | - | $4.65 M(-4.1%) |
Dec 2019 | $4.85 M(>+9900.0%) | $4.85 M(-15.5%) |
Sept 2019 | - | $5.74 M(-2.8%) |
June 2019 | - | $5.90 M(-2.7%) |
Mar 2019 | - | $6.07 M(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00 |
Dec 2016 | $212.00 K | - |
FAQ
- What is Crinetics Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly total debt year-on-year change?
What is Crinetics Pharmaceuticals annual total debt?
The current annual total debt of CRNX is $51.73 M
What is the all time high annual total debt for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual total debt is $51.73 M
What is Crinetics Pharmaceuticals quarterly total debt?
The current quarterly total debt of CRNX is $52.54 M
What is the all time high quarterly total debt for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly total debt is $53.32 M
What is Crinetics Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, CRNX quarterly total debt has changed by +$811.00 K (+1.57%)